Close Menu

People with sickle cell disease are hopeful that the gene-editing tool CRISPR might be able to offer them relief, Technology Review reports.

"Patients are very intrigued by [CRISPR]. They think it sounds wonderful," Biree Andemariam, director of the New England Sickle Cell Institute at the University of Connecticut Health Center, tells Tech Review.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.